Diagnostic Image Quality and Safety of Low-Volume, Low-Concentration, Iso-Osmolar Contrast Medium in the Computed Tomographic Workup of Patients Considered for TAVR
Phase of Trial: Phase IV
Latest Information Update: 26 Mar 2018
Price : $35 *
At a glance
- Drugs Iodixanol (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- 20 Mar 2018 Status changed from active, no longer recruiting to completed.
- 21 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Apr 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2016, according to to ClinicalTrials.gov record.